about
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differ...
Read More
111.81
4.65
(4.34%)
128.0K
XNAS Volume
XNAS 22 Jan, 2026 11:15 AM (EST)
Not Eligible
Expensive Valuation
Technically Bullish
Celcuity Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..